| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lyra Therapeutics, Inc. (LYRA) has 7 insiders with recent SEC Form 4 filings, including 12 buys and 7 sells. LYRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.10M | $800.6K | - | |
| CFO | 518.5K | $378.5K | - | |
| Dir | 32.0K | $23.4K | - | |
| Dir | 32.0K | $23.4K | - | |
| Dir | 32.0K | $23.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 5, 2020 | Anderson Edward T | Director, 10% Owner | Sell | 24,183 | $16.00 | $386,928.00 | -1.6% | |
| May 5, 2020 | Polaris Venture Management Co. V, L.l.c. | 10% Owner | Sell | 9,674 | $16.00 | $154,784.00 | -0.9% | |
| May 5, 2020 | Nbvm Gp, LLC | 10% Owner | Buy | 250,000 | $16.00 | $4,000,000.00 | +17.1% | |
| May 5, 2020 | Soleus Private Equity GP I, LLC | 10% Owner | Buy | 155,000 | $16.00 | $2,480,000.00 | New | |
| May 5, 2020 | Anderson Edward T | Director, 10% Owner | Buy | 250,000 | $16.00 | $4,000,000.00 | +17.1% | |
| May 5, 2020 | Perceptive Advisors LLC51 | Director, 10% Owner | Buy | 625,000 | $16.00 | $10,000,000.00 | +47.7% | |
| May 5, 2020 | Polaris Venture Management Co. V, L.l.c. | 10% Owner | Buy | 62,500 | $16.00 | $1,000,000.00 | +6.0% |